N-(4-propylpyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide → (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(4-propylpyridin-2-yl)benzamide
Reaction equation
[NH2:1][C:2]1[C:3]2[N:4]([C:8]([C@@H:12]3[CH2:16][CH2:15][CH2:14][N:13]3C(OCC3C=CC=CC=3)=O)=[N:9][C:10]=2Br)[CH:5]=[CH:6][N:7]=1.[CH2:27]([C:30]1[CH:35]=[CH:34][N:33]=[C:32]([NH:36][C:37](=[O:53])[C:38]2[CH:43]=[CH:42][C:41](B3OC(C)(C)C(C)(C)O3)=[CH:40][CH:39]=2)[CH:31]=1)[CH2:28][CH3:29]>>[NH2:1][C:2]1[C:3]2[N:4]([C:8]([C@@H:12]3[CH2:16][CH2:15][CH2:14][NH:13]3)=[N:9][C:10]=2[C:41]2[CH:42]=[CH:43][C:38]([C:37]([NH:36][C:32]3[CH:31]=[C:30]([CH2:27][CH2:28][CH3:29])[CH:35]=[CH:34][N:33]=3)=[O:53])=[CH:39][CH:40]=2)[CH:5]=[CH:6][N:7]=1Participants
3
Reactant 2
Product 1
Procedure
This intermediate was prepared, in an analogous manner as described for intermediate 2, from (S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate (Intermediate 1e) and N-(4-Propylpyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (intermediate 8) to afford the title compound (147.8 mg, 93%).
Workup
- customThis intermediate was prepared, in an analogous manner
Sources & evidence
- ORD record
- ord-11608e4e45f44a91b5ad46ce697cc5cb
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09290504B2
Reaction notes
Loading…